Podcasts about ibm watson health

As healthcare systems grapple with persistent staffing shortages and rising patient volumes, the need for streamlined, tech-enabled workflows has become urgent. A 2024 time-motion study across four hospitals found that clinical pharmacists spend over 80% of their time on clinical activities, with nearly 12% dedicated to face-to-face patient interaction. That leaves less than 20% for administrative and logistical tasks like inventory management, highlighting the opportunity for automation to further maximize clinical value. Omnicell's push toward an “autonomous pharmacy” seeks to rebalance this equation by automating routine operations and freeing up clinicians for patient-facing care.Can real-world automation and AI truly relieve cognitive burden without removing the human touch from healthcare?This second episode in a two-part Highway to Health series, hosted by David Kemp, features Omnicell's Randall Lipps, CEO and founder of Omnicell, and Nish Parekh, SVP and Chief Product Officer. They discuss how robotics, RFID, and predictive analytics are transforming medication workflows while restoring human connection in clinical care.Key Takeaways:The Autonomous Pharmacy Vision: Omnicell aims to automate repetitive pharmacy tasks, allowing over 200,000 pharmacists to reengage directly in patient care.Real-World AI and RFID in Action: The lab's MedTrack OR system uses RFID to track anesthesia meds in real time, solving inventory blind spots and reducing manual counts.Collaboration is the Catalyst: Every solution stems from customer-driven feedback. The Innovation Lab is not a showroom—it's a collaborative workspace to solve “big, hairy” problems.Randall Lipps is the founder, chairman, and CEO of Omnicell, where he has led the company from a single-product startup to a global leader in pharmacy automation and medication management. Drawing from his background in airline operations and logistics, he pioneered Omnicell's vision of the Autonomous Pharmacy, now serving over 5,000 hospitals and 40,000 pharmacies worldwide. Lipps also serves on several healthcare and digital health advisory boards and is recognized for his leadership in automation, innovation, and operational efficiency.Nish Parekh is a healthcare technology executive and current SVP and Chief Product Officer at Omnicell, where she leads global product strategy, innovation, and marketing. Her career spans leadership roles at IBM Watson Health, Epic, and AppliedVR, with a focus on AI, digital therapeutics, and advancing pharmacy automation. A recognized voice in health tech, she has been featured in Fast Company, spoken at SXSW and CES, and was named one of the Top 50 Women Leaders in Health Tech.

In The Digital Executive podcast, Dr. Oliver Degnan, a pioneering technology executive and leadership coach, discusses his extensive experience in AI and healthcare innovation. With leadership roles at IBM Watson Health, Intuit, and major healthcare organizations, Dr. Degnan shares how AI is revolutionizing patient care, operational efficiency, and physician burnout prevention. He emphasizes the importance of designing AI solutions that integrate seamlessly into healthcare workflows, acting as supportive companions rather than intrusive tools. His insights highlight how AI-driven diagnostics, predictive analytics, and automation are transforming both the patient and provider experience. Dr. Degnan also delves into leadership challenges faced by tech executives transitioning from hands-on roles to strategic decision-making. He stresses the need for balancing innovation with stability, developing strong communication skills, and prioritizing human-centric technology solutions. By fostering a leadership approach that prioritizes real-world problem-solving over mere technological capability, he helps organizations achieve sustainable progress. For a deeper dive into his insights, tune in to the full podcast episode.

In this episode of The Digital Executive podcast, Dr. Oliver Degnan, a pioneering technology executive and leadership coach, discusses his extensive experience in AI and healthcare innovation. With leadership roles at IBM Watson Health, Intuit, and major healthcare organizations, Dr. Degnan shares how AI is revolutionizing patient care, operational efficiency, and physician burnout prevention. He emphasizes the importance of designing AI solutions that integrate seamlessly into healthcare workflows, acting as supportive companions rather than intrusive tools. His insights highlight how AI-driven diagnostics, predictive analytics, and automation are transforming both the patient and provider experience.Dr. Degnan also delves into leadership challenges faced by tech executives transitioning from hands-on roles to strategic decision-making. He stresses the need for balancing innovation with stability, developing strong communication skills, and prioritizing human-centric technology solutions. By fostering a leadership approach that prioritizes real-world problem-solving over mere technological capability, he helps organizations achieve sustainable progress. For a deeper dive into his insights, tune in to the full podcast episode.

In this bonus episode of Problem Solved: The IISE Podcast, we present Mandy Long's keynote address from the Healthcare Systems Process Improvement Conference 2025 in Atlanta. With a distinguished background in artificial intelligence and healthcare technology, including leadership roles at IBM Watson and Experian Health, Mandy explores the practical application of AI in healthcare. She emphasizes the importance of tailoring AI to solve real, human-centered problems, avoiding vendor lock-in, focusing on measurable outcomes, and recognizing the enduring role of human expertise alongside AI.Learn more about the HSPI conference at: iise.org/HSPI

This week we sit down with M.H. Lines, founder of Stack Moxie, to explore how automated testing and monitoring can prevent Martech failures. M.H. shares insights from her experience as a marketing operations leader and explains why many revenue teams are still vulnerable to unexpected system breakdowns. We dive into the challenges that come with managing complex Martech stacks and why early detection through automated tools is essential for keeping operations running smoothly.M.H. also reflects on her journey from marketing leadership to founding Stack Moxie, including how she navigates being a venture-backed startup without compromising on her core principles. Thanks to Our SponsorMany thanks to the sponsor of this episode - Knak. If you don't know them (you should), Knak is an amazing email and landing page builder that integrates directly with your marketing automation platform. You set the brand guidelines and then give your users a building experience that's slick, modern and beautiful. When they're done, everything goes to your MAP at the push of a button. What's more, it supports global teams, approval workflows, and it's got your integrations. Click the link below to get a special offer just for my listeners. Try Knak About Today's Guest M.H. Lines founded Stack Moxie in 2018 to bridge the gap between engineering and no-code technology for the SaaS economy. She has helped teams in marketing and technology both in-house and as a consultant at companies like Terex, Cohn & Wolfe, Microsoft, Lowes, The Tile Doctor and IBM Watson Health. MH received an undergraduate degree from The Florida State University in Finance, and her MBA from the Foster School of Business, University of Washington with a focus on Technology Management. https://www.linkedin.com/in/mhlines/Key Topics[00:00] - [00:00] - Introduction[01:49] - Secrets to Gap Folding[03:55] - From marketing to MOPS[07:54] - MOPS as strategic vs. service provider[14:28] - Being wired as a founder[17:55] - Working in mega-enterprise[22:59] - Observability for MOPS[34:35] - Observability and AI[39:12] - Being a VC-backed founder Thanks to Our SponsorBig thanks goes out UserGems for sponsoring today's episode. We all know running outbound is a huge pain—you need to manage a dozen different tools and data sources and it takes ton of manual work to keep it all going. UserGems solves that with one platform to capture signals and automate next steps with workflows and AI.You get a library of the most impactful signals in one place, automated playbooks to make sure your team executes consistently, and Gem AI to create personalized messaging for each prospect. So stop wasting time and start targeting your most promising buyers with less headcount. Click the link below for a special offer just for my listeners. Try UserGems Resource LinksThe Official Home of Stack Moxie and Revenue Observability Learn MoreVisit the RevOps FM Substack for our weekly newsletter: Newsletter

Today's guest is Brian Hart, Chief Technology Officer at Covera Health. Founded in 2017, Covera Health is leading the way in the emerging science of quality, deploying AI-powered quality insights to aid healthcare providers and payers in a shared quest to better define, measure and deliver the highest standard of care to patients everywhere. From helping people access the most effective care to providing doctors with powerful tools and insights, they are working to improve outcomes and care quality for all. Brian brings over 20 years of experience leading digital transformation at health technology organizations. Prior to Covera Health, he worked with IBM Watson Health where he oversaw and delivered on strategic imperatives, early innovation, incubation projects and the open source. He also led the AI portfolio focused on high impact disease and cancer detection, quality tools and contextual summarization. Brian has a broad range of experience directly responsible for point of care solutions, radiology information system and revenue cycle management. In today's episode, Brian discusses: His background in HealthTech and journey to Covera Health, His role as the CTO at Covera Health, Addressing radiology inconsistencies with AI for quality improvements, An insight into the day-to-day life of the team, Plans for Platform investment, AI 2.0 transition & LLMs, Career opportunities with Covera Health, What makes Covera Health a great place to work

Yeah, it's a fact that the vast majority of past and present provider and payer relationships are not exactly collaborative. They may better be described as fairly adversarial, actually—especially when viewed through the lens of provider organizations trying really hard to find a payment model that will enable them to do better by their patients and deliver better outcomes. We've had Justina Lehman (EP414), Ali Ucar (EP362), Dan O'Neill (EP359) talking about this from the provider organization standpoint. We also had Dan Serrano (EP410) and Will Shrank, MD (EP413) corroborating here. But after each of these earlier episodes, many comments and conversations ensued about said potential (or not) payer/provider collaborations. And there was a theme of many of these online exchanges. The theme was wondering if we'd all get laughed at for even talking about these rare and elusive Shangri-la scenarios. Like expending words and energy thinking about payers and providers working together was as crazy as being seen earnestly discussing, I don't know, whether mermaids know about pants or something. And that's why I wanted to get Josh Berlin on the podcast today: to talk about the why, the what, and the how of collaboration. I wanted to know if there really is a solid why here for the why collaborate, especially from a payer point of view. And when I say payer, I mean a payer kind of payer like a Blue Cross, United, Cigna, Aetna plan kind of payer. And I'm calling that out because payers are intermediaries in all cases except for their fully insured members. Except for that one book of business, entities actually taking the risk are taxpayers or self-insured employers. So, saving money on its face is not a super compelling value proposition. Listen to the show with David Contorno (EP339) for the why there. As we talk about in the interview that follows, though, what might be compelling is predictable spend, possibly—or even more compelling could be a competitive differentiation for that payer that leads to higher market share. Payer/provider collaborations can also lead to a more resilient market foothold that can stand up to threats from upstart competitors or big tech and big retail swooping in looking for a tasty slice of this $3 trillion industry. There's also the potential for a higher profit margin. And, oh, one additional reason to collaborate if you're a payer that we don't get into super heavily but I'd be remiss to not mention is the whole Star Ratings thing for Medicare Advantage plans, because stars equal big money. But a payer is not gonna get that Star Rating shekel if providers aren't delivering high enough quality care. Also, of course, we have HEDIS (Healthcare Effectiveness Data and Information Set) and other quality measures that have financial value ascribed to them. In the conversation that follows, Josh talks about different types of collaborations. Collaboration is a really very vague term, so what exactly is this collaboration, what does it entail, and how do you do it? Josh told me that there are five kinds of collaboration, and here they are in order of their depth of entanglement, I guess you could call it. 1. Sharing data back and forth 2. Use that data to identify areas of need and then do something programmatic together, like create clinical pathways or work on one very specific type of quality program. 3. A joint venture (JV)—you JV and work together on some sort of narrow network kind of product 4. Become capital partners in some way. 5. Having a risk-bearing kind of relationship—the provider gets a piece of the premium dollar So, that's the five types of collaboration. But here's the things you've got to tick through, that you have to really go through and make sure you've got all these things before you start. Otherwise, it'll be a monumental waste of time. 1. Complementary capabilities that enable scalability 2. A desire for sustainability in a market, and both have common goals and objectives and an agreed-upon time horizon 3. Both parties need to be pretty flexible. Rigid products have a shelf life. You've got to be willing to advance with market dynamics flexibly—know how to iterate around whatever it is you're doing. 4. Excel at collaboration. If you're going to collaborate, you have to know how to collaborate. And that's a cultural thing. 5. Compatible risk profiles—this means not just “taking risk” but knowing how to do it in a way that will work and navigating around things that could cause trouble when moving from fee for service to a more capitated way of going about things. Josh talks about some of them. Just to loop back around on #4 there, because … yeah, to collaborate, you need to collaborate. I call Josh out on this one, and he reiterates that … yeah, nothing to take for granted here. It might seem obvious, but it's so frequently an internal unknown unknown—at a lot of payers especially. I mean, if I'm a provider organization and you force me to only communicate with you through snail mail (ie, postage stamp, letter box, the whole nine), I don't know, I'd kind of get the vibe that I'm being enthusiastically ignored, which I just cannot square with a collaborative spirit of any kind. Josh Berlin is a founding partner of Rule of Three, which is a consulting firm. Rule of Three has clients that are physician practices, hospitals, health systems on the traditional side; and they also work with nontraditional organizations like Walmart Health and Wellness. They also work with payers, like regional blues and employer plans.   You can learn more at Rule of Three and by connecting with them on LinkedIn.   Josh M. Berlin, JD, is CEO of Rule of Three, LLC, with more than 25 years of experience, most of which has been in healthcare advisory in service to his clients. Most recently, he has served as principal and co-practice leader of Citrin Cooperman's Healthcare Practice and managing partner for IBM Watson Health's Strategic Advisory Practice, leading a unique group of consultants in each instance to serve clients across the full healthcare ecosystem (providers, payers, employers, governments, advocacy, etc). Prior to those roles, Josh served as a principal in the healthcare consulting practice at Dixon Hughes Goodman (now FORVIS), helping to lead their strategy consulting business, and served as a leader in all versions of KPMG (KPMG Consulting/BearingPoint and KPMG). Currently, he serves on the Boards of the Validation Institute, Population Health Management journal, and HealthTrackRx. Josh's expertise spans both the consulting and healthcare industries. Some of his clients have included the Hospital Corporation of America, the Department of Health and Human Services (including the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services), various pediatric health systems, the National Association for Healthcare Quality, Nebraska Medicine, Penn Medicine, the Ochsner Health System/Network, the BJC Collaborative, and The Leapfrog Group, as well as a variety of other healthcare organizations. Josh has developed long-standing client relationships at all levels of organizations, notably including some of the most prestigious C-suite executives in healthcare today.   06:06 Why should payers want to collaborate with providers? 09:46 “Collaboration … is bilateral. … Both sides, plan and provider, should be equally as interactive with the individual populations they work with.” 12:37 What are the must-haves for collaboration between providers and payers? 13:10 What are the five different types of collaboration? 16:03 What are the five characteristics you want to be focused on in partnership? 21:35 EP359 with Dan O'Neill. 22:16 In order to collaborate, do you have to be collaborative? 26:11 Ochsner as a great example of collaboration. 27:46 Episodes with David Carmouche, MD, and Eric Gallagher. 28:51 A collaboration failure in Haven.   You can learn more at Rule of Three and by connecting with them on LinkedIn.   Josh M. Berlin of Rule of Three, LLC, discusses #payer and #provider #collaboration on our #healthcarepodcast. #podcast #digitalhealth #valuebasedcare #healthcare   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Adam Brown, Rob Andrews, Justina Lehman, Dr Will Shrank, Dr Carly Eckert (Encore! EP361), Dr Robert Pearl, Larry Bauer (Summer Shorts 8), Secretary Dr David Shulkin and Erin Mistry, Keith Passwater and JR Clark (Summer Shorts 7), Lauren Vela (Summer Shorts 6)  

Tune in for today's industry updates.

About Jaime Murillo:Dr. Jaime Murillo is a Senior VP and the Chief CardioMetabolic Health Officer at Optum Labs. He is focused on disruptive care delivery solutions to improve health in the community using AI-powered technology, social-behavioral determinants of health, and community-based collaboration. His work also includes advanced analytics to identify gaps in care with an emphasis on health equity and AI/ML-based phenotyping and multi-omics to advance precision medicine. Before his current role at Optum Labs, he spent 2 years at UnitedHealthcare as the national lead for cardiovascular and ED services. This work focused on simple innovation and value-based transformation of care and affordability. He is a cardiologist from Yale University with a background in computer sciences and basic science and clinical research at Harvard Medical School and outcomes research at Yale University.He is a former IBM Watson Health collaborator on the clinical implementation of machine learning in the cardiovascular field. He practiced cardiology with a subspecialty in imaging for 20 years at Sentara Health. Within Sentara, he played several executive roles with a focus on leadership development and consumer strategies. Outside of work Jaime enjoys watching his son play tennis, watching movies with his wife, and practicing Pilates. Things You'll Learn:In healthcare, communication is one of the areas with significant improvement opportunities.By 2025, about $300 billion in care will be delivered to consumers' homes.UnitedHealth Group also works with a sense of purpose, their recent merger with LHC seeks to build care in communities and at homes.Healthcare solutions today are based on clinical components and other different determinants of health.Algorithms can now be built to allow the identification of those who may have a condition before it develops any complications.Medical solutions today cannot exclusively take into account clinical data, they need to look at the patient holistically.  Resources:Connect with and follow Jaime Murillo on LinkedIn.Follow Optum Labs on LinkedIn.Discover the Optum Labs Website!

How can Artificial Intelligence be used to promote health equity? How does the history of racism in the United States impact the representation of marginalized people in healthcare research? In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, meditation expert, and tapping practitioner, interviews experts and gives her own insights into multiple fields relating to social justice and anti-racism. In this episode, Jill interviews Dr. Irene Dankwa-Mullan, Chief Health Equity Officer and Deputy Chief Health Officer at IBM Watson Health. They discuss her work at the intersection of healthcare, public health, and technology, which uses artificial intelligence to personalize healthcare for individuals within a larger system. Dr. Dankwa-Mullan highlights the importance placed on minimizing human bias in AI programs so it can successfully promote health equity. BIO: Irene Dankwa-Mullan MD MPH is a nationally recognized industry physician and scientist, health equity thought leader, scholar, and author with over 20 years of diverse local-regional, national, and global leadership experience in primary care, healthcare systems, businesses, and the community. She is a member of the IBM Industry Academy, a selected community of pre-eminent leaders to drive innovation and engage in cutting-edge work. She is the lead scientific editor of the first authoritative resource textbook ‘The Science of Health Disparities Research' designed to identify research questions, guide collaborative and participatory efforts with communities to promote health equity. LINKS: LinkedIn: Irene Dankwa-Mullan MD MPH Twitter: @dankwairene The Science of Health Disparities Research - by Eliseo J. Pérez-Stable and Irene Dankwa-Mullan and Kevin L. Gardner

Lorraine Marchand is Executive Managing Director of Merative (formerly IBM Watson Health) and has three decades of experience in new product development. She has held leadership positions at Bristol Myers Squibb, Covance, Cognizant, and IQVIA, and has cofounded four companies. Marchand is an adjunct professor of management and serves on the Healthcare and Pharmaceutical Management Program Advisory Board at Columbia Business School and is an adjunct professor of innovation and entrepreneurship at Yeshiva University's Katz School of Science and Health. She is also an investor-member of venture firm Plum Alley. Her new book, THE INNOVATION MINDSET: Eight Essential Steps To Transform Any Industry, was recently published by Columbia University Press.

Lorraine Marchand is the  Executive Managing Director of Merative (formerly IBM Watson Health). In this episode, they talk about how innovation thrives in environments that embraces uncertainty, being 'unsuccessful', and the ability to pivot.More about our guest:Lorraine Marchand  has three decades of experience in new product development. She has held leadership positions at Bristol Myers Squibb, Covance, Cognizant, and IQVIA, and she cofounded four companies. Marchand is an adjunct professor of management and serves on the Healthcare and Pharmaceutical Management Program Advisory Board at Columbia Business School and an adjunct professor of innovation and entrepreneurship at Yeshiva University's Katz School of Science and Health. She is also an investor-member of venture firm Plum Alley.------------------------------------------------Episode Guide:1:23 - What is Innovation?  2:41 - Unveiling adulthood curiosity6:09 - The practice of noticing8:25 - Jeff Bezos' Amazon and incentivized failure11:22 - Problem Solving Methods and Innovation: First Principles12:52 - Method 2: reframing14:01 - Method 3: Analogy / Metapor technique16:09 - Innovation: the cultural aspect17:05 - What isn't innovation?  17:42 - Serendipity Innovation: Upjohn company's Rogaine19:05 - Disruptive Innovation / Big hunt innovations19:35 - Field of Dreams Innovation22:45 - Unlearning ways of thinking23:28 - Innovation: Shaping Careers27:31 - Advice to Innovators-------------------------OUTLAST Consulting offers professional development and strategic advisory services in the areas of innovation and diversity management.

On this week's episode of Inside Outside Innovation, we sit down with Lorraine Marchand. Lorraine is the author of the new book, The Innovation Mindset. She and I discuss how innovation starts, how you can build your muscle of innovation through exploration and experimentation, and much more. Let's get started.Inside Outside Innovation is the podcast to help new innovators navigate what's next. Each week we'll give you a front row seat into what it takes to learn, grow, and thrive in today's world of accelerating change and uncertainty. Join us as we explore, engage, and experiment with the best in the brightest, innovators, entrepreneurs, and pioneering businesses. It's time to get started.Interview Transcript with Lorraine Marchand, Author of The Innovation MindsetBrian Ardinger: Welcome to another episode of Inside Outside Innovation. I'm your host, Brian Ardinger, and as always, we have another amazing guest. Today we have Lorraine Marchand. She is executive managing director of Merative, which is formerly IBM Watson Health. And she's author of the new book, The Innovation Mindset: Eight Essential Steps to Transform Any Industry. Welcome to the show, Lorraine. Lorraine Marchand: Thank you, Brian. Really happy to be here. Brian Ardinger: I'm excited to have you. You have been in this space for a while. For the past three decades, you have been in product development, working with companies like Bristol Myers Squibb and Covance, and Cognizant. How did you get involved in the realm of innovation?Lorraine Marchand: Well, it started when I was actually pretty young. I was reared by my dad, who was an inventor. And when I was growing up around the house, he would always challenge my brother and me, to find three solutions to every problem, usually problems that he would identify. And one summer morning, he really brought that point close to home. And he took us to a local diner called the Hot Shops Cafeteria in Wheaton, Maryland.And our job was to determine what was slowing down table turnover. So we sat in the big red vinyl booths eating our breakfast of scrambled eggs and orange juice. And after three days of using our stopwatches and writing down notes, and even interviewing waitresses and bus boys, we determined that the culprit was sugar packets. People were spewing them all over the place. True to his tenant that we had to find three solutions we did. And we ended up taking one to an MVP, minimal viable prototype. And that was the sugar cube. And we ended up selling it to the Hot Shops cafeteria that summer, and pretty soon it was distributed throughout the Baltimore Washington area.So early on, I learned that problem solving was fun and lucrative. And fast forward throughout my career, whether it was at the National Institutes of Health or Bristol Myers Squibb, or founding my own startups and the diagnostics and ophthalmology area, I found that I really did love this idea of being able to clearly define a problem, and then as my dad had taught me kind of systematically evaluate and choose solutions. And to me, the heart of the innovation mindset that I write about is an insatiable curiosity, a passion for problem solving, and embracing change. And so I have found myself, whether in large corporations or in startups, desiring to be that agent of change and bringing that problem solving methodology that I learned so early at the age of 13 with me in all of my career endeavors. Brian Ardinger: I love that story and I love, you have this in the book that one of the key mindset essential steps is this innovation starts with at least three ideas. Can you talk a little bit more about why it takes more than one idea to get something going and that process? Lorraine Marchand: You know, I like to say that first of all, your first two ideas, one of them is probably a solution that you've already been mulling over before you even confirmed that you had a problem. Because I find that we, as human beings, love to go into solutioning mode before we've really carefully defined the problem. So, if you are making your way around a problem, you probably have a bias in terms of what one of the solutions is. The second solution is always to do nothing, right? The competition is always the default, the status quo, I'm not going to change.So right there, you already have number one and two. So you have to be true to the problem solving discipline and this idea of brainstorming and coming up with the three solutions, because it could be that third one that is the winner. If you go a little bit beyond the three, I'm okay with that, but I don't allow my students or any of the individuals I coach to cheat and come up with fewer than three. That you can't do Brian Ardinger: That makes perfect sense. Like you said, you've been in this space for a long time and you've, you've helped create products, you've helped create companies and that. What are some of the biggest maybe obstacles or misconceptions that people have about innovation and starting this particular process.Lorraine Marchand: I think a lot of people are intimidated that they think that innovation has to be at the hands of some of the quintessential greats like Edison and Jobs and Musk and Gates, etc. And so, the first thing I like to do is educate and inform individuals that not all forms of innovation are disruptive. They're not all big hunt. And it is absolutely honorable, and it could be your style of innovation to create incremental improvements. To do more renovation, retooling something for another type of use case. To be optimizing, which actually my story about the Hot Shops Cafeteria, truly if I'm honest about it, it's more about optimizing than truly innovating.But I'm okay with that because like you, I'm very passionate about just encouraging more people to access the freedom, the excitement, the job satisfaction that comes from innovating. And I'm okay to use a broader set of terminology in order to attract more people to just find ways to get started. So that's the first thing. I think people are really put off by that. And then I think that a lot of innovators find that it's very difficult to do customer research. Where do I find the customer? How do I talk to them? Do they want to talk to me? How do I really write a question guide that doesn't bias them toward my solution? So that's one that is very difficult to do, and I find that a lot of individuals will gloss over it. You know, I, I say you have to talk to a hundred customers. And my students look at me with their eyes crossed going, I can't possibly do that. I can't even find five. And I say, well, how are you going to sell your product if you can only find five people to talk to about it? Okay. Right there. And then I would say the other area is pivot. I'm a real fan of pivoting you never fail. Some people will argue with me, but I like to say, you don't fail if you're constantly adjusting your strategy based on the data, based on the market dynamics, and you're moving in the direction where you keep learning and improving what you're doing and moving it closer to the customer. We don't fail, we pivot. But a lot of founders, fail to see the warning signs. That maybe things aren't taking off the way they thought. And so pivoting too late can be pretty dangerous. Brian Ardinger: You spent some time both in bigger corporations as well as a startup entrepreneur. Do you see any differences about how those types, either early-stage startups innovate versus bigger companies, and what are the differences and similarities?Lorraine Marchand: I think that one of the big challenges in a corporation is, number one, the corporation exists in order to systematize, routinize, and scale. So, by its very nature, it's not really incented to be an innovative type of organism because innovation is the opposite. Innovation is about experimentation. It's got to create a safe environment for you to try something and fail. The only time I'll use the word fail. You have to be able to experiment and know that it's not gonna move forward. And as we both know, so often corporations living quarter by quarter, they just don't have a lot of patience for investing time, money, and important talent and resources in creating new ideas that might not make it to market.So that's one of the biggest challenges, and I tell my corporate colleagues who wanna innovate or even head up innovation, how important it is to embed it in the culture. And one of the first tips that I give them is you have to create an environment where experimentation is encouraged, and failure feels safe.And failure is also even encouraged and incentivized. And I do like the way Jeff Bezos positioned that within Amazon. So, he had try, fail, learn. And if I had to reiterate a mantra to my friends in the corporate world, it would be you have to create that kind of environment. And if he did it, with a logistics company, surely you can do it too. Brian Ardinger: Absolutely. It's interesting to talk a little bit about that. You know, you mentioned earlier about how you define innovation. And I think that's so important in that early-stage process to get people comfortable with the fact that I can be an innovator even though I'm not a Steve Jobs.The idea that just taking an idea and creating value around that idea, that's how I define innovation. You know, being able to take your idea and move it forward to create value from it. That alone gives the individual person on the line permission to see a problem and say, I can fix that. And that is innovation and appreciate that particular type of approach.It also then allows you to start building that muscle. To take on maybe bigger things down the road, bigger, more adjacent or transformational types of innovation. As you kind of learn about the process and learn that anybody can go through the part of taking an idea and creating value from it.Lorraine Marchand: I really love that, Brian. In fact, I love that metaphor of the muscle. I was talking with one of the innovators that I profiled in the book, Sarah Apgar, who invented a piece of fitness equipment called the Fit Fighter. She's just phenomenal. It's a nationally recognized business and brand now, and so we use that metaphor when we were talking about Fit Fighter and innovation that it's like a muscle.I might have a goal of doing a half marathon. And I go out in day one, I've never run before. But I'm going to run half a mile and then the next week I'm going to run another half a mile and I'm going to build up to it. Because building a muscle, practicing is what makes you the half marathon runner. And building the muscle and practicing is what makes you good at innovating.Brian Ardinger: So, you mentioned one of the stories that is in your book, but the book is packed full with a variety of different case studies and and things that you've seen along the lines. Can you tell us some of the success stories that you highlight in the book? Lorraine Marchand: You know, one that I don't often get an opportunity to talk about. So, thank you for letting me choose one of my favorites. I had a fantastic opportunity when I was a professor of entrepreneurship at Princeton, to judge a business pitch contest at a prison in a local New Jersey County. And so that day I drove out to the prison not really knowing what to expect. And it was just the most enlightening and humbling experiences that I had.The inmates had really worked hard over the 12 weeks in the entrepreneurship program. And they had studiously written their business plans down on loose leaf paper with pencils. And so, when I came in, I read the plans and then they had an opportunity to present their ideas and to pitch their ideas to me. And they were so engaged in the feedback. So responsive and receptive to it, and they really just wanted to learn and get better. And you could just feel the energy in the room. But the best part of the story was three of those gentlemen went on to found the businesses that we had discussed in the session that day. And even though I couldn't stay in touch with them because of rules around these sorts of engagements, I was able to get information from the warden later that they had been successful. And really not too many stories have warmed my heart like that one. Brian Ardinger: It's excellent to see that again pretty much anybody from anywhere can find problems to solve, and if you go through a process to make that happen, you can actually create value and change lives, so that's amazing. The other thing I like about your book, you have a section in there talking about women innovators and some of the unique challenges that they face. Can you talk a little bit more about that? Lorraine Marchand: My focus on women is around increasing awareness and raising women up and encouraging them to step up and stand out and give innovation a try. And I just think that for a lot of women, it's not something that they naturally think about being entrepreneurs or innovators.And we do find that the data indicates that even among venture capital firms, there's still only about 2 to 3% of them that have women partners. And when we look at investments in women founded companies, it's also still hovering at around 2 to 3%. And I'm just such a fan of innovation for all the reasons that we've talked about because I think it can be so satisfying to take an idea, to take a problem that you've personally observed and bring it to life, bring it to market as we've been discussing. I think that's tremendously satisfying. And I also think that it can be economically satisfying and help women find economic freedom. And a sustainability of their economic freedom and status. So I want to get the word out. I really encourage women in STEM. I encourage women to figure out ways to access capital. And I have a resource guide to help women with that. And then very importantly, I like to help women think a little differently about their own networking. And the truth of the matter is you have to be comfortable networking with accountants and attorneys and investors, and maybe not those folks that are in your social circles on a day-to-day basis, but you have to get out there and be able to have those conversations and pull those people into your network. So those are some of the tips that I give to women. Brian Ardinger: They're great tips and they apply to everyone as far as that ability to build a network. I think a lot of people think of innovation as this sport that you do in your garage and the tinkerer who figures things out on their own. But like you said, there are so many different components that have to come together to create that value, whether it's the accountants or the lawyers or the other people that can help build the product, whatever the case may be. Collaborative nature of innovation is so important. How do you stay fresh and current and connected with the new things that are going on in your world, and how do you stay on the top of, of your game? Lorraine Marchand: Well, I am always reaching out to new innovators. I get so much inspiration from the students that I teach at a graduate level. Or I'll be going to the Philadelphia Venture Fair later this week. And so, I'll get to talk to the early-stage entrepreneurs there. And share ideas and explore and create with them. So, I need to put myself in an environment where I'm around innovators too and entrepreneurs and I feed off of their energy. So that really is what does it for me, is just staying out there with other people, with ideas that want to create and grow. And by linking arms, we move this whole movement forward and it keeps me fresh too. Brian Ardinger: It's always important to keep in touch with where those new ideas are coming from and that. Do you see any new trends or things that you're excited about? Lorraine Marchand: I think the area of AI is absolutely fascinating. You know, I was recently reading a report that AI innovation about a 1.1 billion cagr, but the fastest growing area, even though it's very much focused on manufacturing, automation, automobiles, for example, the fastest growing sector is in healthcare. And I just think that's incredibly exciting if you think about the ability to use artificial intelligence on information about a patient's cancer tumor, have it diagnosed earlier, precision medicine in terms of knowing how to treat it.Or even being able to develop the sensors that can go into devices and help to measure and monitor pain or someone's activity around the house. So, I definitely love the healthcare applications of AI, one of those areas that I'm particularly passionate about. For More InformationBrian Ardinger: I want to thank you for coming on Inside Outside Innovation, to kind of share your insights and that. Look forward to having the conversation again in the future as we talk more about some of the crazy things that are happening in the world. If people want to find out more about yourself or more about your book, what's the best way to do that?Lorraine Marchand: I'm on LinkedIn, so I'd love for you to connect with me, Lorraine Marchand on LinkedIn. And if you would like a copy of the book, it's on Amazon, The Innovation Mindset with my name. You can buy a copy there and you can also go to the Columbia University Press website, and you can also purchase the book through Columbia. Brian Ardinger: Well, Lorraine, thanks again for being on the show. Appreciate the time and looking forward to continuing the conversation in the future. Lorraine Marchand: Thank you, Brian, and continued good luck with all of your fabulous endeavors as well.Brian Ardinger: Thank you. That's it for another episode of Inside Outside Innovation. If you want to learn more about our team, our content, our services, check out InsideOutside.io or follow us on Twitter @theIOpodcast or @Ardinger. Until next time, go out and innovate.FREE INNOVATION NEWSLETTER & TOOLSGet the latest episodes of the Inside Outside Innovation podcast, in addition to thought leadership in the form of blogs, innovation resources, videos, and invitations to exclusive events. SUBSCRIBE HEREYou can also search every Inside Outside Innovation Podcast by Topic and Company.  For more innovations resources, check out IO's Innovation Article Database, Innovation Tools Database, Innovation Book Database, and Innovation Video Database.  

Hosted by Andrew Keen, Keen On features conversations with some of the world's leading thinkers and writers about the economic, political, and technological issues being discussed in the news, right now. In this episode, Andrew is joined by Lorraine H. Marchand, author of The Innovation Mindset: Eight Essential Steps to Transform Any Industry. Lorraine Marchand is general manager of life sciences at IBM Watson Health and has three decades of experience in new product development. She has held leadership positions at Bristol Myers Squibb, Covance, Cognizant, and IQVIA, and she cofounded four companies. Marchand is an adjunct professor of management and serves on the Healthcare and Pharmaceutical Management Program Advisory Board at Columbia Business School. Learn more about your ad choices. Visit megaphone.fm/adchoices

From working nights in the Prudential mailroom during college to securing leadership roles at big names like IBM Watson Health, Allscripts, and Pfizer, Steve Tolle, now general partner at HLM Venture Partners, has seen it all. With a multi-faceted skill set and a wealth of knowledge in technology and healthcare, he eventually transitioned from an operator to an investor at one of the nation's oldest and most established healthcare venture capital firms. Given his background, it is no surprise that Tolle knows a thing or two about the growing needs of the healthcare industry and how to spot a winning investment. In this episode, Tolle speaks with Breaking Health host Steve Krupa about HLM's focus on behavioral health, member engagement, access to care, value-based care enablement, and tech-enabled services. He also talks about the six-point test every company must pass before he considers investing and what each founder should know to win over investors in under five minutes. Links from this episode:  HLM Venture Partners HealthEdge Software 

This week we discuss VMware Explore, Snap's move to multi-cloud and the Galaxy Brain take on thought leadership. Plus, Matt Ray's latest Raspberry Pi project is for the birds…? Runner-up Titles Where's my admin? All my children qualify as adults Start by eating their food Put two letters in front of it Where's the grocery store I got that everything bagel spice Is it OK to hang-up on your kids? In the heat of the moment, you can't set policy. The runbook's already written. Spagetti Bowl Tanzu the Shih Tzu A FinOps Type of Motion The opposite of the Sales Kickoff, the Savings Kickoff Growth is best done in the shadows. Wrapping bullshit with bullshit Nopehouse, home of the fast follower The fast followers are just in front of the also-rans Thought-leadership suicide mission Rundown VMware Explore (https://www.vmware.com/explore/us.html) How Snap rebuilt the infrastructure that now supports 347M users (https://www.protocol.com/enterprise/snap-microservices-aws-google-cloud) Screaming in the Cloud with Martin Casado (https://www.lastweekinaws.com/podcast/screaming-in-the-cloud/the-new-cloud-war-with-martin-casado/) Give finops a say over cloud architecture decisions (https://www.infoworld.com/article/3671148/give-finops-a-say-over-cloud-architecture-decisions.html) Business Dudes Need to Stop Talking Like This (https://newsletters.theatlantic.com/galaxy-brain/630ec150bcbd490021b17eab/business-dudes-need-to-stop-talking-like-this/) Relevant to your Interests Amazon tries a new way to excite you about cybersecurity (it's called laughter) (https://www.zdnet.com/article/amazon-tries-a-new-way-to-excite-you-about-cybersecurity-its-called-laughter/) The golden noose around Apple's neck (https://spectatorworld.com/topic/the-golden-noose-around-apples-neck/) Campaign pushes Cloudflare to drop trans hate site (https://www.axios.com/newsletters/axios-login-85e45e2f-8629-43d3-be69-45072a3631f5.html?chunk=0&utm_term=emshare#story0) Mudge at Twitter (https://twitter.com/igb/status/1562427951882199044) Bloomberg takes cut and paste seriously (https://twitter.com/MidwestHedgie/status/1562450905907478531) Notice of Recent Security Incident - The LastPass Blog (https://blog.lastpass.com/2022/08/notice-of-recent-security-incident/) World's Most Popular Password Manager Says It Was Hacked (https://www.bloomberg.com/news/articles/2022-08-25/the-world-s-most-popular-password-manager-says-it-was-hacked) LastPass Says No Passwords Stolen in Data Breach (https://www.cnet.com/tech/services-and-software/lastpass-says-no-passwords-stolen-in-data-breach/) AWS and Kubecost collaborate to deliver cost monitoring for EKS customers | Amazon Web Services (https://aws.amazon.com/blogs/containers/aws-and-kubecost-collaborate-to-deliver-cost-monitoring-for-eks-customers/) Pandas Pivot Table Explained (https://pbpython.com/pandas-pivot-table-explained.html) Charted: Big Tech's bigness (https://www.axios.com/newsletters/axios-login-3db6f78d-4da1-494b-a5d4-04c8984ce0e5.html?chunk=1&utm_term=emshare#story1) UK's Micro Focus shares nearly double after Canada's OpenText agrees $6 bln takeover (https://www.reuters.com/markets/deals/canadas-opentext-buy-software-firm-micro-focus-6-bln-deal-2022-08-25/) Teradata takes on Snowflake and Databricks with cloud-native platform (https://venturebeat.com/data-infrastructure/teradata-makes-database-analytics-cloud-native/) The State of the Mainframe Market - Summer 2022 (https://futurumresearch.com/market-insight-reports/the-state-of-the-mainframe-market-summer-2022/) City2Surf face recognition raises concerns (https://ia.acs.org.au/content/ia/article/2022/city2surf-face-recognition-raises-concerns.html) IBM Watson Health layoffs disguised as staff 'redeployment' (https://www.theregister.com/2022/08/29/ibm_allegedly_hid_watson_health/) David Young on LinkedIn: The metaverse economy is set to boom... gambling will be a significant (https://www.linkedin.com/posts/david-young-b5276523_metaverse-5g-localisation-activity-6966387069338218496-4x5F?utm_source=share&utm_medium=member_desktop) OCI History (https://twitter.com/solomonstre/status/1564499775415676928) VMware CEO bats away Broadcom concerns as 'next transition' (https://www.theregister.com/2022/08/30/vmware_broadcom_/) Heroku to delete inactive accounts, shut down free tier (https://www.theregister.com/2022/08/25/heroku_delete_inactive_free_tier/) Cloudflare Is One of the Companies That Quietly Powers the Internet. Researchers Say It's a Haven for Misinformation (https://time.com/6208828/cloudflare-misinformation-internet-research/) Nonsense Sounds right (https://twitter.com/6thgrade4ever/status/1433519577892327424?s=20&t=o8cx7C7pcCkVR4cTcQbv4g) When the development team meet their first Scrum Master (https://twitter.com/onejasonknight/status/1564287640366628866?s=20&t=y3AIxGPb8kge28aICQ6dFQ) Chart of the year nominee (https://twitter.com/jpwarren/status/1564109454009716736/photo/1) Conferences DevOps Talks Sydney (https://devops.talksplus.com/sydney/devops.html), Sydney, September 6-7, 2022 Sydney Cloud FinOps Meetup (https://events.finops.org/events/details/finops-sydney-cloud-finops-presents-sydney-cloud-finops-meetup/), online, Oct 13, 2022 Matt's presenting Kube (https://events.linuxfoundation.org/kubecon-cloudnativecon-north-america/https://events.linuxfoundation.org/kubecon-cloudnativecon-north-america/)C (https://events.linuxfoundation.org/kubecon-cloudnativecon-north-america/https://events.linuxfoundation.org/kubecon-cloudnativecon-north-america/)o (https://events.linuxfoundation.org/kubecon-cloudnativecon-north-america/https://events.linuxfoundation.org/kubecon-cloudnativecon-north-america/)n North America (https://events.linuxfoundation.org/kubecon-cloudnativecon-north-america/https://events.linuxfoundation.org/kubecon-cloudnativecon-north-america/), Detroit, Oct 24 – 28, 2022 SpringOne Platform (https://springone.io/?utm_source=cote&utm_medium=podcast&utm_content=sdt), SF, December 6–8, 2022 THAT Conference Texas Call For Counselors (https://that.us/call-for-counselors/tx/2023/) Jan 16-19, 2023 Listener Feedback Enlightning (https://tanzu.vmware.com/developer/tv/enlightning/) from Whitney SDT news & hype Join us in Slack (http://www.softwaredefinedtalk.com/slack). Get a SDT Sticker! Send your postal address to stickers@softwaredefinedtalk.com (mailto:stickers@softwaredefinedtalk.com) and we will send you free laptop stickers! Follow us on Twitch (https://www.twitch.tv/sdtpodcast), Twitter (https://twitter.com/softwaredeftalk), Instagram (https://www.instagram.com/softwaredefinedtalk/), LinkedIn (https://www.linkedin.com/company/software-defined-talk/) and YouTube (https://www.youtube.com/channel/UCi3OJPV6h9tp-hbsGBLGsDQ/featured). Use the code SDT to get $20 off Coté's book, (https://leanpub.com/digitalwtf/c/sdt) Digital WTF (https://leanpub.com/digitalwtf/c/sdt), so $5 total. Become a sponsor of Software Defined Talk (https://www.softwaredefinedtalk.com/ads)! Recommendations Brandon: Black Bird (https://www.rottentomatoes.com/tv/black_bird/s01) Matt: BirdNetPi (https://birdnetpi.com/) Festival of Feet Half-Marathon (https://www.westiesjoggers.com/the-georges-river-festival-of-the-feet/) Coté: Spigen ArcDock 120W [GaN III] 4-Port USB C Charging Stantion USB-C PD/USB-A Hub with Spigen USB 4 Cable for Thunderbolt 4 Cable 100W Charging 40Gbps Data Transfer for MacBook Pro Air iPad USB-C Laptop (https://amzn.to/3RqRl7M). C7/C8 coupler cables Photo Credits CoverArt (https://unsplash.com/photos/Ts3yX7wDthw) Banner (https://unsplash.com/photos/hXttDVCwyRA)

What BIG thing is Avaneer Health building with its $50 million SEED round backed by not-just-investors-but-also-partners CVS Health, Aetna, Anthem, Cleveland Clinic, HCSC, PNC Bank, Sentara Healthcare and IBM Watson Health? CEO Stuart Hanson stops by to clear-up the mystery that IS Avaneer Health, and how the massive data exchange platform it's building is meant to connect the data coming out of the biggest payers and biggest providers in healthcare, directly and in real-time. Hang on – is this the blockchain-based data exchange healthcare has been talking about for more than a decade?? It sure is trying to be. And what Stuart says is different about Avaneer's effort is, indeed, the fact that it's backed by some of the biggest brands in the business and that they see the business case in being able to more effectively share their data with one another. As he explains it, “this problem of data interoperability and data fluidity is bigger than any competitive business model that they need to worry about…” Stuart is careful to explain what Avaneer IS and what it IS NOT, and this is critical to the company's growth plans and revenue model. Avaneer is NOT a data intermediary; it's not about aggregating data, normalizing it, de-identifying it, or applying any fancy machine learning algorithms to it to deliver “insights” on it. Avaneer is strictly a platform for secure, compliant data exchange, so, for example, Anthem can connect to Cleveland Clinic in real-time and verify insurance coverage. The revenue model is currently built around access to the network and will one-day-soon also take in fees from ‘Solutions Innovators' (aka data-aggregating, algorithm-loving, insights-dropping health tech companies) that will offer their services as add-on's to Avaneer's customers who are plugged into the network. What's ahead for this stealthy start-up as it scales? Could they REALLY be looking to raise a follow-on seed round?? Find out what kind of investors they're looking for and what's ahead on their product roadmap in this in-depth chat. *** Jessica DaMassa, the emerging ‘It girl' of health tech interviewing, chats it up with the ‘who's who' of the health tech and healthcare innovation set on 'WTF Health - What's the Future, Health?' Catch 100's of interviews with leading health tech startups and the VC investors, health insurance companies, big pharma co's, and hospital systems helping bring their new ideas into the healthcare establishment. From AI and Big Data to digital health, virtual care, telehealth, digital therapeutics, payment model innovation, and investing, Jessica helps you spot the trends and figure out what's next. Subscribe to WTF Health's YouTube Channel: https://www.youtube.com/wtfhealth Follow Jess DaMassa on Twitter: https://twitter.com/jessdamassa Visit WTF Health: https://www.wtf.health "WTF Health - What's the Future, Health?" is sponsored in part by OneDrop, Transcarent, Pfizer, Wheel, Vida Health, 120/80 MKTG, Komodo Health, Newtopia, & Bayer G4A. Special thanks to our distribution partner, The Health Care Blog. To learn more about WTF Health or throw some sponsorship dollars at our show yourself, check out www.wtf.health.

On Episode 10, the final episode of Season 1 of The Game-Changing Women of Healthcare, Meg is joined by Deborah DiSanzo, President of Best Buy Health. Meg and Deborah discuss the untold origins of the podcast. Deborah speaks of her early days with Apollo Computer and the surprising turn her career path took leading her to Hewlett Packard, Philips Healthcare, and IBM Watson Health. Deborah explains the strategic variables and decisions they faced in entering the automated external defibrillator market and what she values most about her teaching appointment at Harvard's TH Chan School of Public Health. DiSanzo also shares her vision for the role Best Buy Health will play in enabling healthcare in the home.About Deborah DiSanzoAs President of Best Buy Health, Deborah Disanzo is responsible for the company's health strategy, with a particular focus on bringing health technology into the home. With more than 30 years of experience at the intersection of healthcare and technology, Deborah was previously CEO of Philips Healthcare and held management positions at Hewlett Packard and Apollo Computer.At Philips, she and her team brought consumer-grade automated external defibrillators to the market, making them first available in public places, then ultimately into the homes of Americans across the country. At IBM Watson health, she helped launch artificial intelligence offerings designed to help doctors, researchers, healthcare providers, pharmacists and insurers better serve patients around the world. Deborah is also an instructor at the Harvard's TH Chan School of Public Health.Further Reading:Philips HeartStartPhilips Cardiology InformaticsUniversity of Pittsburgh Center for AI Innovation in Medical ImagingDana-Farber Cancer InstituteMD Anderson Cancer CenterCorrie Barry, CEO Best BuyThe HP Way: How Bill Hewlett and I Built Our Company by David Packard (212 pages, Harper Business, 1995)Episode Credits: The Game-Changing Women of Healthcare is a production of The Krinsky Company. Hosted by Meg Escobosa. Produced, edited, engineered, and mixed by Calvin Marty. Theme music composed and performed by Calvin Marty. Intro and outro voiced by John Parsons. ©2022 The Krinsky Company

Ricoh USA's Gary Turner, Managing Director of Additive Manufacturing in North America, discusses the company's recent 3D printing efforts in the healthcare space. Along with sharing the benefits of the RICOH 3D for Healthcare solution (an end-to-end workflow solution for designing and producing 3D-printed anatomic models), he talks about affordability and ease of use, as the solution integrates with IBM Connect Access from IBM Watson Health—enterprise imaging software many healthcare providers already use.

In this month's podcast, Medtech Insight's Reed Miller reports on IBM Watson Health's divestiture, Barnaby Pickering discusses his Exec Chat with Bloom Diagnostics, autonomous robots and Philips' ultrasound game. Al-Faruque (Danny) Ferdous highlights the latest digital health regulatory news. Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode: Exec Chat: Bloom Diagnostics' Chair Discusses The Future Of At-Home Lateral Flow Testing Philips Steps Up Ultrasound Game With Lumify 4.0 Minute Insight: Can Robots Do Surgery Without Human Help? IBM Divests Watson Health Assets To Focus On Cloud And AI Businesses Experts: New Cybersecurity Standard Goes Beyond What US And Other Regulators Require FDA Continues To Down-Classify Digital Health Apps With New Cardio App Rule

In this episode, we welcome Raj Jhaveri, an Investor, Visionary Technologist, and Strategist in the healthcare and biotech industry, as well as in the clean energy sector particularly in EV charging. Tune in to learn how Raj is making an impact, in more ways than one, in digital healthcare innovation and the future of telehealth.You'll learn how artificial intelligence is being implemented in healthcare management and delivery systems, how ingestible capsules and wearables can be integrated with AI to enhance healthcare, and how the integration of emerging technologies is causing disruptive innovation throughout the world.Raj shares his candid thoughts on the connection between AI, Theory of Mind, and the future of in-person healthcare, as well as potential opportunities to invest in healthcare and technology and even how he's hacking his Tesla to give back to the energy grid.Curious to hear Raj's 5 Pillars of Unconventional Thinking to Achieve Unconventional Success? Tune in to find out! To learn more about Raj and his work, visit his website: www.rajjhaveri.com About Our Guest:Raj Jhaveri has over 16 years of experience in technology development and integration, and strategic technical business development in both the healthcare and cleantech industry. He was a CTO and founder of multiple healthcare startups (Notch, Canopy, Face2Face Health, Manethryn, Opu Labs) where he earned multiple patents, which lead to being rated as one of the Top Tech Innovators by Entrepreneur Magazine in 2014. He was also a Director for The Knowledge Society, a global community and a human accelerator program of the world's most curious, driven, and ambitious people that want to make an impact.Raj has also played a role as an advisor or investor at multiple companies such as EV Connect, Zoom Video, Pinterest, Chewy.com, Slack, Impossible Foods, 23andMe, Simple Contacts, and many more. He was previously an in-house mentor at Techstars, an industry consultant for General Catalyst Partners in regard to their healthcare investments, and an advisor for IBM Watson Health's Oncology Project. He holds a Bachelor of Science degree in Mathematics and Biology and was in the MD/PhD program at Harvard Medical School and the Massachusetts Institute of Technology where he eventually obtained a Master's Degree in Medical Sciences after leaving the program early to pursue his first startup.  Connect with Raj on LinkedIn: www.linkedin.com/in/rajpjhaveri Visit his website: www.rajjhaveri.com Follow him on Twitter: www.twitter.com/rajpjhaveri Follow him on Instagram: www.instagram.com/theurbannerd  About SmartTab: SmartTab is driving the future of digital medicine by developing a superior patient-centered personalized drug delivery platform in the form of a wireless ingestible capsule. The patient experience fuels SmartTab's commitment to create novel, effective therapies that improve patient outcomes and compliance. For more information visit: www.smarttab.co

Original Air Date: Feb 12, 2022We welcome back John Mathis for Part 2 of our conversation on his NDE, OBEs, Remote Viewing and more!3rd Eye Salon:Thanks: https://ko-fi.com/3rdeyesalon/ (Buy 3rd Eye Salon a Coffee!)Community: https://www.facebook.com/groups/3rdeyesalonEvents: https://www.facebook.com/3rdEyeSalonEventsHomepage: https://www.3rdeyesalon.com/Telegram: https://t.me/ThirdEyeSalonApple Podcast: https://podcasts.apple.com/us/podcast/3rd-eye-salon/id1603899554Spotify: https://open.spotify.com/show/0YartXNwExBpXdHDsVOehr?si=eb8066da1b03445fOur guest, John Mathis, is a polymath and a spiritual paramedic. He's a clinical researcher who has brought medications to market like Humira, Rogaine, and Gemzar. He pioneered the conversion of paper based data collection to electronic data collection during Y2K and 9/11. He has followed data from the street to the spreadsheet.He's a vocalist who has been singing since he was 6 years old. Between 18 and 27 years old, he was a professional operatic bass-baritone who sang in 5 languages, he opened for the Oak Ridge Boys and performed for President Reagan. He also did voice over work using his "cartoon" and "tractor pull" voices. He reports breaking into song upon the opening of a third bottle of wine.He has college degrees in English Literature, Music Performance and Nursing. He taught himself database and website programming and was a platform member of IBM-Watson Health until he asked Watson how much guacamole could fit into a tuba. He was both admonished and recognized by upper management for the question.He started 3 companies, written two books, and is working on a third.And... He's with us today for none of those reasons. He's here today because he talks to spirits, does remote viewing of the solar system, had a near death experience that included Quiddich, had subsequent shared near death experiences with his cancer patients, and has uncovered 14 previous lifetimes. Most recently, he was introduced to a trans-dimensional entity who identified themselves as "The Architect" following several rounds of ketamine therapy.He calls himself a metaphysical practitioner, an alchemist, and a meat suit driver. Today, we're going to pop the bunghole on this keg and partake of what we find.My friends - our guest and the author of this very intro - John MathisJohn Mathis:https://www.johnmathis.me/index.html  - books, talks, YouTube channel, medium.comhttps://jmathisrn.medium.com/  -  Most popular article: Consciousness Journal: Reiki — My Master Attunement and How I Drove My Guardian Angel to DrinkLeast popular: Consciousness Journal: Remote Viewing the Moon and the Junkyardwww.youtube.com/c/johnmathisrn  - NDE, Past lives, Reiki, Tarot, Remote Viewing, and other meat suit adventureswww.rhine.org  - the nexus of PSI research / Transpersonal Psychology, remote viewing classes, paranormal investigation classes,www.aciste.com  - following my heart after my NDEwww.iands.com - following my brain after a NDEwww.silva.org - smashing silos and creating my own Unified TheoryCoHosts:Michele Amburgey:Hompage: https://www.micheleamburgey.com/YouTube: https://www.youtube.com/c/MicheleAmburgeyAngela Anderson: Homepage: www.onenessworksllc.simplybook.me/v2/Youtube: https://www.youtube.com/channel/UCR4G3I3YCJKfHMtRLmxTcVw#NDE #NearDeathExperience #RemoteViewing #Researcher #Reiki #PastLives #Spiritual #OBE #AstralTravel #AstralProjection #SpiritualHealing ★ Support this podcast ★

Ведущие подкаста "Data Coffee" обсуждают новости и делятся своими мыслями! Shownotes: 02:37 Auchenberg/volkswagen определяет, что тесты зап... 05:37 История с распределенной базой на sqlite развив... 10:27 10 лет AWS DynamoDB - NoSQL база данных single-... 13:52 Отличия в парсерах PNG у Apple и остальных 20:31 Майнинг в Иркутске 23:23 EdgeDB 1.0 release - first open source graph-re... 27:41 Стартап Engineer.ai, позиционирующий себя как р... 33:34 Описываем свой SQL на естественном языке и выпо... 37:01 Закрывают IBM Watson Health по кускам и продают... 37:18 Интересная штука, может попробую: естественный... 40:40 После анализа бигдаты было принято решение увол... 42:18 Рабочих мясокомбината в Набережных Челнах «пром... 53:57 Живая нейросеть общего назначения 56:10 Дрон гоняет голубей в Швейцарии смотреть до кон... 01:01:21 Атаки на NLP-системы: невидимые пробелы, подмен... 01:09:33 Айтишник не может зарабатывать меньше 4000$, он... Обложка - Smallbones, CC0, via Wikimedia Commons Сайт: https://datacoffee.site, канал в Telegram: https://t.me/datacoffee, профиль в Twitter: https://twitter.com/_DataCoffee_ Чат подкаста, где можно предложить темы для будущих выпусков, а также обсудить эпизоды: https://t.me/datacoffee_chat

In Episode 6, Season 4—the 50th guest episode—of the Amplifying Scientific Innovation® Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Irene Dankwa-Mullan, Chief Health Equity Officer, Deputy Chief Health Officer, IBM Watson Health and Member of the IBM Industry Academy. IBM Watson Health aspires to improve lives and give hope by delivering innovation to address the world's most pressing health challenges through data and cognitive insights. In this recognition of Black History Month, Dr. Dankwa-Mullan discusses her perspectives on science advocacy, health equity and influential leadership. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-%2B-articles/f/amplifying-scientific-innovation%C2%AE-ibms-dr-irene-dankwa-mullan

Host: Dr. Wendy Marie Ingram, PhD, Co-Founder and CEO of Dragonfly Mental Health and Research Scientist at Geisinger Health Guest: Irene Dankwa-Mullan, MD, MPH - A nationally recognized physician, researcher, and industry thought leader working at the intersection of healthcare, health equity, public health Informatics, data science, and applied artificial intelligence. She serves as the Chief Health Equity Officer and Deputy Chief Health Officer at IBM Watson Health. Live from AMIA 2021 Annual Symposium,  an intimate conversation with the closing speaker about HI, the human side of artificial intelligence

DeepBrain AI's industry-first approach to "humanizing" AI assistants provides users with a familiar, insightful, and accessible experience. https://gadget.co.za/ces-2022-deepbrain-humanises-ai-avatars/ It's amazing what we can do with AI these days. https://www.pcgamer.com/nvidias-upgraded-ai-art-tool-turned-my-obscure-squiggles-into-a-masterpiece/ IBM has revived its sale process for IBM Watson Health with hopes of raising more than $1 billion, people familiar with the situation tell Axios. https://www.axios.com/ibm-tries-to-sell-watson-health-again-82f691a4-ab81-4b2b-a5bb-13a7556c8ef1.html French drugmaker Sanofi SA (SASY.PA) will partner with British AI company Exscientia Plc (EXAI.O) to develop up to 15 drug candidates in oncology and immunology, under an agreement worth up to $5 $.2 billion in milestone payments, the two companies said on Friday. https://www.reuters.com/markets/europe/sanofi-partners-with-ai-firm-exscientia-develop-up-15-new-drugs-2022-01-07/ People use AI for a variety of speech recognition and language understanding tasks, from activating smart speakers to building tools for people with hearing or speech disabilities. https://ai.facebook.com/blog/ai-that-understands-speech-by-looking-as-well-as-hearing Visit www.integratedaisolutions.com

Podcast jest dostępny także w formie newslettera: https://ainewsletter.integratedaisolutions.com/ Pierwsze w branży podejście DeepBrain AI do „humanizowania” asystentów AI zapewnia użytkownikom doświadczenie, które jest znajome, pouczające i przystępne. https://gadget.co.za/ces-2022-deepbrain-humanises-ai-avatars/ To niesamowite, co możemy obecnie zrobić za pomocą sztucznej inteligencji. https://www.pcgamer.com/nvidias-upgraded-ai-art-tool-turned-my-obscure-squiggles-into-a-masterpiece/ IBM wskrzesił proces sprzedaży IBM Watson Health, mając nadzieję na zarobienie ponad 1 miliarda dolarów, mówią Axiosowi ludzie zaznajomieni z sytuacją. https://www.axios.com/ibm-tries-to-sell-watson-health-again-82f691a4-ab81-4b2b-a5bb-13a7556c8ef1.html Francuski producent leków Sanofi SA (SASY. https://www.reuters.com/markets/europe/sanofi-partners-with-ai-firm-exscientia-develop-up-15-new-drugs-2022-01-07/ Ludzie wykorzystują sztuczną inteligencję do szerokiego zakresu zadań związanych z rozpoznawaniem i rozumieniem mowy, od włączania inteligentnych głośników po opracowywanie narzędzi dla osób niedosłyszących lub cierpiących na zaburzenia mowy. https://ai.facebook.com/blog/ai-that-understands-speech-by-looking-as-well-as-hearing Odwiedź www.integratedaisolutions.com

Der branchenweit erste Ansatz von DeepBrain AI zur „Humanisierung“ von KI-Assistenten bietet Benutzern ein vertrautes, aufschlussreiches und zugängliches Erlebnis. https://gadget.co.za/ces-2022-deepbrain-humanises-ai-avatars/ Es ist unglaublich, was wir heutzutage mit KI machen können. https://www.pcgamer.com/nvidias-upgraded-ai-art-tool-turned-my-obscure-squiggles-into-a-masterpiece/ IBM hat seinen Verkaufsprozess für IBM Watson Health wiederbelebt, mit der Hoffnung, mehr als 1 Milliarde US-Dollar zu erzielen, sagen mit der Situation vertraute Personen gegenüber Axios. https://www.axios.com/ibm-tries-to-sell-watson-health-again-82f691a4-ab81-4b2b-a5bb-13a7556c8ef1.html Der französische Arzneimittelhersteller Sanofi SA (SASY.PA) wird mit dem britischen KI-Unternehmen Exscientia Plc (EXAI.O) zusammenarbeiten, um bis zu 15 Arzneimittelkandidaten in den Bereichen Onkologie und Immunologie zu entwickeln, im Rahmen einer Vereinbarung im Wert von bis zu 5,2 Milliarden US-Dollar an Meilensteinzahlungen, sagten die beiden Unternehmen am Freitag. https://www.reuters.com/markets/europe/sanofi-partners-with-ai-firm-exscientia-develop-up-15-new-drugs-2022-01-07/ Menschen nutzen KI für eine Vielzahl von Spracherkennungs- und Sprachverständnisaufgaben, von der Aktivierung intelligenter Lautsprecher bis hin zur Entwicklung von Tools für Menschen mit Schwerhörigkeit oder Sprachbehinderungen. https://ai.facebook.com/blog/ai-that-understands-speech-by-looking-as-well-as-hearing Visit www.integratedaisolutions.com

3rd Eye Salon:Thanks: https://ko-fi.com/3rdeyesalon/ (Buy 3rd Eye Salon a Coffee!)Community: https://www.facebook.com/groups/3rdeyesalonEvents: https://www.facebook.com/3rdEyeSalonEventsHomepage: https://www.3rdeyesalon.com/Telegram: https://t.me/ThirdEyeSalonApple Podcast: https://podcasts.apple.com/us/podcast/3rd-eye-salon/id1603899554Spotify: https://open.spotify.com/show/0YartXNwExBpXdHDsVOehr?si=eb8066da1b03445fOur guest, John Mathis, is a polymath and a spiritual paramedic. He's a clinical researcher who has brought medications to market like Humira, Rogaine, and Gemzar. He pioneered the conversion of paper based data collection to electronic data collection during Y2K and 9/11. He has followed data from the street to the spreadsheet.He's a vocalist who has been singing since he was 6 years old. Between 18 and 27 years old, he was a professional operatic bass-baritone who sang in 5 languages, he opened for the Oak Ridge Boys and performed for President Reagan. He also did voice over work using his "cartoon" and "tractor pull" voices. He reports breaking into song upon the opening of a third bottle of wine.He has college degrees in English Literature, Music Performance and Nursing. He taught himself database and website programming and was a platform member of IBM-Watson Health until he asked Watson how much guacamole could fit into a tuba. He was both admonished and recognized by upper management for the question.He started 3 companies, written two books, and is working on a third.John Mathis:https://www.johnmathis.me/index.html  - books, talks, YouTube channel, medium.comhttps://jmathisrn.medium.com/  -  Most popular article: Consciousness Journal: Reiki — My Master Attunement and How I Drove My Guardian Angel to DrinkLeast popular: Consciousness Journal: Remote Viewing the Moon and the Junkyardwww.youtube.com/c/johnmathisrn  - NDE, Past lives, Reiki, Tarot, Remote Viewing, and other meat suit adventureswww.rhine.org  - the nexus of PSI research / Transpersonal Psychology, remote viewing classes, paranormal investigation classes,www.aciste.com  - following my heart after my NDEwww.iands.com - following my brain after a NDEwww.silva.org - smashing silos and creating my own Unified TheoryCoHosts:Michele Amburgey:Hompage: https://www.micheleamburgey.com/YouTube: https://www.youtube.com/c/MicheleAmburgeyAngela Anderson: Homepage: www.onenessworksllc.simplybook.me/v2/Youtube: https://www.youtube.com/channel/UCR4G3I3YCJKfHMtRLmxTcVwIntro/Outro Music: Music: technology upbeat loop by ispeakwaves and Hula Hoop Party by JeffSpeed68 ★ Support this podcast ★

The Game-Changing Women of HealthcareEpisode 3 - Tina Moen  “Humans Helping Humans”Today, on our third episode, host Meg Escobosa welcomes Tina Moen, GM IBM Micromedex & Chief Pharmacy Officer, IBM Watson Health.Meg and Tina discuss Tina's overnight decision to become a pharmacist, her inspiration and evolution as a leader, her view of the value of the interplay between technology, AI and humans in healthcare - above all to serve patients. She shares the biggest challenges we face and how to keep teams motivated in the uphill climb of launching new solutions.About Tina Moen:Tina Moen, GM IBM Micromedex & Chief Pharmacy Officer, IBM Watson Health, leads the Micromedex team providing clinical decision support for medication, disease, patient education, and toxicology decisions within healthcare organizations around the globe. Dr. Moen previously led a clinical team working across Watson Health to provide clinical leadership and support for strategy and sales. Before joining IBM, Tina served as VP of Client Strategy for Health Language, part of Wolters Kluwer Health, where she collaborated with clients delivering a solution to unlock data and drive semantic interoperability across the enterprise. She also made an impact in several departments of Truven Health Analytics, as the Vice President of Provider Analytics and as the Chief Clinical Officer.Early in her career she was a pharmacist in pediatrics, home healthcare, HIV, and organ transplantation. Tina received her Doctor of Pharmacy degree from Creighton University.LinkedIn | Twitter: @TinaMoenPharmDFurther Reading: IBM MicromedexIBM Watson HealthTaco BellAdverse Drug Reactions explainerEpisode Credits: The Game-Changing Women of Healthcare is a production of The Krinsky Company. Hosted by Meg Escobosa. Produced, edited, engineered, and mixed by Calvin Marty. Theme music composed and performed by Calvin Marty. Intro and outro voiced by John Parsons. ©2021 The Krinsky Company

In this week's episode Avi shares his incredible story as a doctor willing to embrace change and follow his passions. We talk about his career transitions from the NHS to industry roles such as Clinical Fellow to the NHS National Medical Director, Bupa's Clinical Lead for Digital Health and IBM Watson Health.  We discover the founding story of 'Doctorprenuers', the reality of entrepreneurship and if it really is something we should all pursue, why he believes every clinician should complete foundation training and the power of mentorship. Avi touches upon the life of a clinician in startups, consultancy, corporations, and his new role as Associate partner in IBM's Global Business Services division.  Dr Avi Mehra is an Associate Partner for Healthcare and Life Sciences at IBM and Co-Founder of Doctorpreneurs. In 2014, he joined Bupa as a Clinical Fellow to the NHS National Medical Director, after which he was appointed as Bupa's Clinical Lead for Digital Health. In 2016, Avi joined IBM's newly formed healthcare technology and AI business unit, IBM Watson Health, where he held multiple global leadership roles before recently taking on a new role as an Associate Partner in IBM's Global Business Services division.  
 Avi is also a Fellow at the Faculty of Clinical Informatics, advisor/mentor to digital health startups and mentor on the NHS Clinical Entrepreneur Programme.  LinkedIn: Dr Avi Mehra   Learn more about Scrubbed In: YouTube: Scrubbed In with Amz & Abdul Twitter -@ScrubbedIn_ Instagram - @Scrubbedin_   Check out our latest platform Peerr Peerr socialises education by providing an interactive and collaborative way to learn from your peers through custom-made quizzes.

Join the Pharmacy Podcast Network and IBM Watson Health for another podcast episode focused on how to improve efficiencies across your organizations' drug shortage management and supply chain. Listen to three experts discuss: -                Drug shortage management and prevention – from classification and communication to key stakeholders to how COVID-19 has impacted hospital drug shortages -                The role of technology & data in assisting pharmacists in solving these inventory and management challenges  -                How automation and emerging technology can help pharmacists provide the best care for their patients   OrbitalRX, now with IBM Micromedex, combines real-time inventory awareness and clinical decision support capabilities to help hospital pharmacies proactively manage drug shortages and efficiently identify effective alternatives. View the latest evidence-based treatment information, check your hospital's current drug inventory status, and provide purchasers with a consolidated view of procurement options – all within a single solution. Learn more here: https://www.ibm.com/products/orbitalrx   Guests:  -                Nate Peaty, PharmD, MS, Chief Strategy Officer and Co-founder | OrbitalRX   -                Brian Spoelhof, PharmD, Assistant Manager of Pharmacy - Medication Utilization Strategy | University of Virginia -                Chris Virgilio, PharmD, BCPS Clinical Program Director, Micromedex | IBM Watson Health Learn more about your ad choices. Visit megaphone.fm/adchoices

Join the Pharmacy Podcast Network and IBM Watson Health for another podcast episode focused on how to improve efficiencies across your organizations' drug shortage management and supply chain. Listen to three experts discuss: -                Drug shortage management and prevention – from classification and communication to key stakeholders to how COVID-19 has impacted hospital drug shortages -                The role of technology & data in assisting pharmacists in solving these inventory and management challenges  -                How automation and emerging technology can help pharmacists provide the best care for their patients   OrbitalRX, now with IBM Micromedex, combines real-time inventory awareness and clinical decision support capabilities to help hospital pharmacies proactively manage drug shortages and efficiently identify effective alternatives. View the latest evidence-based treatment information, check your hospital's current drug inventory status, and provide purchasers with a consolidated view of procurement options – all within a single solution. Learn more here: https://www.ibm.com/products/orbitalrx   Guests:  -                Nate Peaty, PharmD, MS, Chief Strategy Officer and Co-founder | OrbitalRX   -                Brian Spoelhof, PharmD, Assistant Manager of Pharmacy - Medication Utilization Strategy | University of Virginia -                Chris Virgilio, PharmD, BCPS Clinical Program Director, Micromedex | IBM Watson Health Learn more about your ad choices. Visit megaphone.fm/adchoices

The Affordable Care Act reaffirmed the centrality of primary care as the foundation supporting the entire American health care system. In today's podcast, the NextGen Advisors discuss a report written in collaboration between the Robert Graham Center, the American Board of Family Medicine, and IBM Watson Health titled, "Primary care in the United States a Chartbook of Facts and Statistics". The Advisors provide their views on this interesting, updated snapshot of the state of primary care in the United States.

The Game-Changing Women of HealthcareEpisode 1 - Tracy Byers: Getting Comfortable with Being UncomfortableToday, on our very first episode, host Meg Escobosa welcomes Tracy Byers, Senior Vice President and General Manager of Enterprise Imaging at Change Healthcare.Meg and Tracy talk about what got Tracy hooked in healthcare, some of her early category-creating successes, and the invaluable mentorship and coaching she received that informed her own leadership style. They also discuss the keys to driving successful innovation on teams and the promise of cloud computing in healthcare today.About Tracy Byers: Tracy Byers is Senior Vice President and General Manager of Enterprise Imaging at Change Healthcare, a 14-year old healthcare technology company, focused on accelerating the transformation of the healthcare system through the Change Healthcare Platform providing data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system. In January 2021, UnitedHealth Group's OptumInsight unit agreed to acquire Change Healthcare in a deal valued at $13 billion.Since beginning her tenure at Change Healthcare in 2019, Tracy has been responsible for driving growth, expanding market share, and advancing the company's position as a transformational leader in the imaging market. Tracy has over 25 years of experience in the healthcare technology industry, including executive leadership roles at IBM Watson Health, Philips Healthcare, Agilent Technologies, Hewlett Packard, and GE. She holds a Bachelor of Science degree in finance from Lehigh University and an MBA from Northeastern University.LinkedIn | Twitter: @TWByersFurther Reading:  Merger of Change Healthcare and United Healthcare Group's Optum Insight Unit Press Release - HP Medical's acquisition of HeartStream LA Times article describing the opportunity in AEDs IBM Watson Health Episode Credits: The Game-Changing Women of Healthcare is a production of The Krinsky Company. Hosted by Meg Escobosa. Produced by Wendy Nielsen and Calvin Marty. Edited, engineered, mixed, and mastered by Calvin Marty. Theme music composed and performed by Calvin Marty. Intro and outro voiced by John Parsons. Cover design by Paul Huber.  ©2021 The Krinsky Company

This week, James is joined by Avi Mehra, a medical doctor by background and Associate Partner for Healthcare at IBM. He is also the Co-Founder of Doctorpreneurs, a non-profit organisation and global community for medical innovators and entrepreneurs. Avi began his career as a doctor in the NHS before transitioning from clinical practice to industry roles. In 2014, he joined Bupa as a Clinical Fellow to the NHS National Medical Director, as part of a year-long NHS leadership and management fellowship programme, after which he was appointed as Bupa's Clinical Lead for Digital Health. In 2016, Avi joined IBM's newly formed healthcare technology and AI business unit, IBM Watson Health, where he held multiple global leadership roles. Avi is also a Fellow at the Faculty of Clinical Informatics, and advisor/mentor to digital health start-ups through the NHS Clinical Entrepreneur Programme among other programmes and initiatives. Get in touch with Avi: Website: www.avimehra.com Email: avi@doctorpreneurs.com Linkedin: linkedin.com/in/avimehra3 Twitter: @aviam3 Subscribe to Healthtech Pigeon

Suzanne Delbanco speaks with Dr. Irene Dankwa-Mullan, Chief Health Equity Officer at IBM Watson Health and Deputy Chief Health Officer within the Center for AI, Research & Evaluation. As an industry physician and scientist working at the intersection of AI, health equity, and health care, Dr. Dankwa-Mullan speaks to best practices for employers interested in measuring and addressing health inequities being experienced by those in their health benefits program, building on a Health Affairs article that she co-authored in December of 2020. Dr. Dankwa-Mullan cites definitions pioneered by Dr. Paula Bravemen for understanding what health equity and health disparities signify in the context of health care benefits. Health equity calls on stakeholders to focus on the unfair differences in health experienced by social groups based on the varying degrees of social advantages and disadvantages conferred to these groups, often across socially constructed racial and ethnic groupings. Diving deeper, Dr. Dankwa-Mullan highlights the lack of a uniform approach to collecting race and ethnicity data for use in addressing disparities. Amidst the lack of standardization and other challenges, the most important best practice is to have patients and/or plan members self-identify their race, ethnicity, primary language, and other cultural attributes that are important to their identity. Self-identification avoids inaccurate and incomplete categorizations. As employers and other stakeholders know all too well, health care benefits are a costly line item in any organization's budget. But inequitable health care adds even more costs. Dr. Dankwa-Mullan offers the following rationales for why employers should collect and measure health statistics by race and ethnicity. 1. To ensure that the employer's investment is reaching the full covered population in an equitable manner 2. To discover opportunities to improve population health 3. To demonstrate an organizational commitment to health equity Altogether, Dr. Irene Dankwa-Mullan highlights the need for employers and their business associates – including TPAs, consultants, and other partners - to acknowledge that health inequities exist and use their role as plan sponsors and benefits administrators to address them through comprehensive, data-driven, health equity strategies.

How the use and training of AI-based medication management will impact hospital pharmacy. IBM® Micromedex® with Watson™ combines evidence-based drug content with advanced AI search capabilities to deliver rapid, reliable answers at the point of care. Improve care experiences and efficiency with insights into drug selection, dosing, toxicology and IV compatibility – accessible from your EHR, computer or mobile device. Primer, 101 for AI in Pharmacy – terminology, examples in med use process Augmented intelligence vs. Artificial intelligence, leveraging the strengths of computers and clinicians together to obtain improved outcomes for patients Why should you know this area? Domain expert and contribute as a translator, clinical voice in the room Hierarchy of AI from AI to Deep Learning Critical components of high-fidelity AI – volume of data, algorithms-built w/out confirmational bias, recurring opportunities for evolution, training the models, et. Can we include a call out to Micromedex with Watson as a specific type of AI/Use Case in everyday clinical practice? https://www.ibm.com/products/micromedex-with-watson Guests: Whitley Yi, PharmD, BCPS, Digital Health, Pharmacy Specialist at Well and Co-Founder of AI Collective Scott Nelson, PharmD, MS, CPHIMS, FAMIA, Program Director, MS Applied Clinical Informatics (MSACI), Assistant Professor, Biomedical Informatics, Assistant Clinical Director, HealthIT, Vanderbilt University Medical Center Arti Bhavsar, PharmD, Clinical Program Director, IBM Watson Health See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

How the use and training of AI-based medication management will impact hospital pharmacy. IBM® Micromedex® with Watson™ combines evidence-based drug content with advanced AI search capabilities to deliver rapid, reliable answers at the point of care. Improve care experiences and efficiency with insights into drug selection, dosing, toxicology and IV compatibility – accessible from your EHR, computer or mobile device. Primer, 101 for AI in Pharmacy – terminology, examples in med use process Augmented intelligence vs. Artificial intelligence, leveraging the strengths of computers and clinicians together to obtain improved outcomes for patients Why should you know this area? Domain expert and contribute as a translator, clinical voice in the room Hierarchy of AI from AI to Deep Learning Critical components of high-fidelity AI – volume of data, algorithms-built w/out confirmational bias, recurring opportunities for evolution, training the models, et. Can we include a call out to Micromedex with Watson as a specific type of AI/Use Case in everyday clinical practice?  https://www.ibm.com/products/micromedex-with-watson  Guests:  Whitley Yi, PharmD, BCPS, Digital Health, Pharmacy Specialist at Well and Co-Founder of AI Collective Scott Nelson, PharmD, MS, CPHIMS, FAMIA, Program Director, MS Applied Clinical Informatics (MSACI), Assistant Professor, Biomedical Informatics, Assistant Clinical Director, HealthIT, Vanderbilt University Medical Center Arti Bhavsar, PharmD, Clinical Program Director, IBM Watson Health See omnystudio.com/listener for privacy information.

Dusty Majumdar, PhD is a senior executive leader in healthcare and life sciences for the last couple of decades and has been in leading positions in companies like GE Healthcare, IBM Watson Health, Exact Sciences and a range of start-ups. Dusty has provided inspirational leadership across various initiatives in healthcare and life sciences including diagnostic imaging, AI, liquid biopsies and more recently RWD/RWE leveraging clinico-genomic data across organizations like CancerLinQ with ASCO and a number of start-ups in the Boston/Cambridge/NYC area, both as the Chief Marketing and Strategy Officer and Chief Commercial Officer.  He has led the commercialization of more than 20 AI based products across Oncology, Genomics, Population Health and Imaging over the last 6 years.  More recently he has been involved with organ-on-chip and organoid-on-chip systems focused on accelerating drug discovery and development through simulating the micro-environment that emulates the natural physiology and mechanical forces that cells experience within the human body.  AI is an integral part of gleaning insights from such systems.

Hitesh is Co-Founder and Co-CEO at Nutromics and is passionate about bring innovative new wearable and AI-driven health-tech products and solutions to the market for impact. Hitesh has more than 10+ years of experience consulting globally within Healthcare and previously worked at IBM Watson Health.

On today's podcast, host Wayne Bowden joins Biorasi's Omar Ibrahim and IBM Watson Health HOPE team members Dr. Mehool Patel and Dr. Dilhan Weeraratne to discuss glioblastoma and the importance of real-world evidence in clinical research.

Dr. Anthony Stanowski is the current President & CEO for the Commission on Accreditation of Healthcare Management Education, otherwise known as CAHME. Dr. Stanowski has held positions at notable organizations such as the Jefferson Health System, Thomson Healthcare (now IBM Watson Health), and Aramark. Dr. Stanowski holds degrees from the University of Pennsylvania, Widener University, Drexel University, and Medical University of South Carolina. Listen in as Dr. Stanowski shares his climb up the healthcare administration ladder, his thoughts on why you should attend a CAHME-accredited program, and advice on what it takes to advance your career.

IBM public health expert on the role of technology in combatting loneliness and supporting good mental health.Guest:Dr. William Kassler has spent his career working at the intersection of clinical care and population health; as a practicing primary care internist, epidemiologist, health services researcher, public sector administrator, and health policy expert. Dr. Kassler currently works at IBM Watson Health as Deputy Chief Health Officer and Lead Health Officer for Population Health, using big data, advanced analytics, and AI to tackle the world's most pressing health challenges.Prior to joining Watson Health, he served as Chief Medical Officer the New England Region of the Centers for Medicare and Medicaid Services (CMS) and was a founding member in the CMSInnovation Center creating value-based purchasing initiatives to improve population health. Before that, he served as the State Health Officer for the New Hampshire Department of Health and Human Services, with leadership and administrative roles in public health, social services, and Medicaid.Dr. Kassler started his career at the Centers for Disease Control and Prevention (CDC) as an EIS officer, later serving as a medical epidemiologist, Branch Chief for Health Services Research andEvaluation, and as Senior Advisor for health policy in the CDC/Washington Office. He received his MD from the University of Massachusetts Medical School, an MS in nutrition from CaseWestern Reserve University, an MPH from Berkeley. He completed a primary care internal medicine residency at Brown and was a Robert Wood Johnson Clinical Scholar at theUniversity of California, San Francisco. Dr. Kassler has been recognized with numerous awards from the United States Public Health Service, including the Surgeon General's Meritorious Service Award. He is the recipient of the NH March of Dimes Physician Leadership Award, and the Bi-StatePrimary Care Association President's Award. He is a practicing internist at a Federally Qualified Health Center and past president of the New Hampshire Medical Society.

IBM Watson Health Recognizes Top-Performing U.S.Hospitals and Health SystemsEkta Punwani, Leader, IBM 100 Top Hospitals Program https://www.linkedin.com/in/ekta-punwani-b1bab87/  Ekta S. Punwani, MHAMs. Punwani is the Leader of the 100 Top Program at IBM Watson Health. She is a trusted advisor to client executives on performance improvement opportunities and strategies based on the 100 Top Program studies. Prior to joining IBM Watson Health, Ms. Punwani served as a Hospital and Health System executive leading organizational transformation, operations improvement, and change leadership within the health care continuum.  She has demonstrated building performance improvement and analytics capability within multiple healthcare organizations including Adventist Midwest Health, Advocate Health Care and Northwestern Medicine. She has served on the Board of Examiners for the National Baldrige Performance Excellence Program for four years and has received certification as an ICBB –International Certified Black Belt.  Ms. Punwani serves on the Health Analytics Advisory Board for Northwestern University in Chicago. She also developed and currently teaches the Health Analytics Leadership course in the Masters of Science in Health Analytics as an Adjunct Faculty.Ms. Punwani received both a Bachelor of Science and a Bachelor of Arts degree from the University of Illinois in Champaign-Urbana and a Master's degree in Health Administration from Washington University in St. Louis.

Our hosts Matt Eyles and Laura Evans are joined by Eric Piscini, Global Vice President of Payer and Emerging Business Networks for IBM Watson Health.

Our hosts Matt Eyles and Laura Evans are joined by Eric Piscini, Global Vice President of Payer and Emerging Business Networks for IBM Watson Health.

Today's guest is Ted Tanner, CTO and Chief Architect at IBM Watson Health. IBM Watson Health aspires to improve lives by addressing the world's most pressing health challenges through data and cognitive insights. Ted is responsible for the technology and platform directives across all of Watson Health genomics, pharmacology and oncology as it pertains specifically to AI-based technologies. From being responsible for C-Level P&L at publicly traded corporations such as Apple and Microsoft, Ted also co-founded startup PokitDok Inc. which was acquired by Change Healthcare in 2018. He also published numerous articles in leading technical magazines and holds several patents in the areas of blockchain, semantics, machine learning, signal processing and signal protection. In the episode, Ted will discuss: The interesting roles he's enjoyed over the years, Transitioning from engineering into running his own business, Learns he has taken into his role at IBM Watson, Exciting projects at IBM Watson Health, such as Genomics & IoT, How to start a career in AI and Machine Learning, And Mentors who guided him in his career.

Sunandini Chopra spends her days working for IBM Watson Health (genomics and oncology). Her free time, however, belongs to AI for the Rest of Us, “a platform that facilitates discussion, problem identification and problem solving to create a positive impact on public health by leveraging machine learning and artificial intelligence.” Platform? It's a community. A discussion group. A gaggle of brainy AI brainstormers. We know because we hosted one of their events, at which Toby Bottorf, VP of Service & Experience Design, gave a sterling talk on AI and human augmentation in healthcare. Chopra visited *The Resonance Test* to report to Bottorf on chatbots, the power of Alexa (“Linked with your phone, with your television, with the speaker in your house, it can take you through the whole route of a digital visual experience, a texting experience, and an audio experience,”) the predictive similarities between meteorology and healthcare, the direction healthcare is heading (“There're two futures: one that's the future for cutting-edge technology and one the future for all the other people in the world to get access to basic care,”) and the adorable nature of RD-D2. *Beep Boop.*